Literature DB >> 18195558

Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes.

Otto O Yang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18195558     DOI： 10.1097/QAD.0b013e3282f29491

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  10 in total

1.  Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppression.

Authors:  Olusimidele T Akinsiku; Anju Bansal; Steffanie Sabbaj; Sonya L Heath; Paul A Goepfert
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

2.  Increasing CTL targeting of conserved sequences during early HIV-1 infection is correlated to decreasing viremia.

Authors:  Otto O Yang; Eric S Daar; Hwee L Ng; Roger Shih; Beth D Jamieson
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-18       Impact factor: 2.205

Review 3.  Good cell, bad cell: flow cytometry reveals T-cell subsets important in HIV disease.

Authors:  Pratip K Chattopadhyay; Mario Roederer
Journal:  Cytometry A       Date:  2010-07       Impact factor: 4.355

4.  Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa.

Authors:  Zabrina Brumme; Bingxia Wang; Kriebashne Nair; Chanson Brumme; Chantal de Pierres; Shabashini Reddy; Boris Julg; Eshia Moodley; Christina Thobakgale; Zhigang Lu; Mary van der Stok; Karen Bishop; Zenele Mncube; Fundisiwe Chonco; Yuko Yuki; Nicole Frahm; Christian Brander; Mary Carrington; Kenneth Freedberg; Photini Kiepiela; Philip Goulder; Bruce Walker; Thumbi Ndung'u; Elena Losina
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

5.  Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines.

Authors:  Patricia L Earl; Catherine Cotter; Bernard Moss; Thomas VanCott; Jeffrey Currier; Leigh Anne Eller; Francine McCutchan; Deborah L Birx; Nelson L Michael; Mary A Marovich; Merlin Robb; Josephine H Cox
Journal:  Vaccine       Date:  2009-08-03       Impact factor: 3.641

6.  Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1.

Authors:  Yaoyu E Wang; Bin Li; Jonathan M Carlson; Hendrik Streeck; Adrianne D Gladden; Robert Goodman; Arne Schneidewind; Karen A Power; Ildiko Toth; Nicole Frahm; Galit Alter; Christian Brander; Mary Carrington; Bruce D Walker; Marcus Altfeld; David Heckerman; Todd M Allen
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

7.  Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruption.

Authors:  Becky Schweighardt; Terri Wrin; Duncan A Meiklejohn; Gerald Spotts; Christos J Petropoulos; Douglas F Nixon; Frederick M Hecht
Journal:  J Acquir Immune Defic Syndr       Date:  2010-01       Impact factor: 3.731

8.  Tracking the culprit: HIV-1 evolution and immune selection revealed by single-genome amplification.

Authors:  Zabrina L Brumme; Bruce D Walker
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

9.  Candidate vaccine sequences to represent intra- and inter-clade HIV-1 variation.

Authors:  Otto O Yang
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

10.  The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT.

Authors:  Sarah Kutscher; Claudia J Dembek; Simone Allgayer; Silvia Heltai; Birgit Stadlbauer; Priscilla Biswas; Silvia Nozza; Giuseppe Tambussi; Johannes R Bogner; Hans J Stellbrink; Frank D Goebel; Paolo Lusso; Marco Tinelli; Guido Poli; Volker Erfle; Heike Pohla; Mauro Malnati; Antonio Cosma
Journal:  AIDS Res Ther       Date:  2008-10-06       Impact factor: 2.250
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.